Godavari Drugs Limited

GODAVARI6

INE362C01012

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 01:33:15 2024-06-03 EDT			5-day change	1st Jan Change
95.3 ^INR	+2.47%		+2.75%	+5.82%

02-13	Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
02-13	Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director	CI

Godavari Drugs Limited Approves the Appointment of Mahindra Uday Bhalerao as Additional Independent Director

November 12, 2022 at 02:06 am

Godavari Drugs Limited at its board meeting held on November 12,2022, approved the appointment of Mr. Mahindra Uday Bhalerao as Additional Independent Director.

Latest news about Godavari Drugs Limited

Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director	02-13	CI
Godavari Drugs' Profit Flat in Fiscal Q2	11-15	MT
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Godavari Drugs Limited Announces Resignation of Ramesh Babu Telugu from the Post of Independent Director	23-08-11	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-21	CI
Godavari Drugs Limited Approves the Appointment of Mr. Venkatesh Achanta as Company Secretary	23-05-29	CI
Godavari Drugs Limited Announces Executive Changes	23-03-15	CI
Godavari Drugs Limited Announces Resignation of Mrs. Rashmi Agarwal as Company Secretary and Compliance Officer	23-02-14	CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Godavari Drugs Limited Appoints Mahendra Uday Bhalerao as Non-Executive Independent Director	22-12-28	CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Godavari Drugs Limited Announces Resignation of Mr. Dilip Keshavlal Patel from Post of Non-Executive Independent Director	22-11-12	CI
Godavari Drugs Limited Approves the Appointment of Mahindra Uday Bhalerao as Additional Independent Director	22-11-12	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-13	CI
Godavari Drugs' CFO Resigns	22-04-20	MT
Godavari Drugs Limited Announces Resignation of Kirti Kumar Jain from the CFO	22-04-20	CI
Godavari Drugs Limited Announces the Resignation of Kirti Kumar Jain from the Office of Whole-Time Director	22-04-20	CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-04-19	CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-04-19	CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-14	CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-16	CI

Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The Company operates through manufacture and sale of API and its intermediates segment. The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for APIâs, drug intermediates and fine chemicals.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GODAVARI DRUGS LIMITED	+5.82%	8.39M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.29%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.58%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.74%	14B
ZYDUS LIFESCIENCES LIMITED	+49.68%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-10.89%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B